Phase 1 Study of Selinexor in Combination With Topoisomerase-II Inhibition in Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Selinexor (Primary) ; Cytarabine; Etoposide; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 02 Apr 2018 Status changed from recruiting to completed.
- 11 May 2017 Status changed from suspended to recruiting.
- 09 Mar 2017 Status changed from recruiting to suspended.